Tag: AFib

Philips announces collaboration with Medtronic to further advance the image-guided treatment of atrial fibrillation

May 9, 2019 Philips’ integrated solution will combine the unique KODEX-EPD dielectric imaging and navigation system, dielectric imaging sensors, clinical software, and services to support cryoablation procedures performed with the Medtronic Arctic Front Advance™ cryoablation technology Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced a collaboration with Medtronic to further advance […]

Acutus Medical Expands AFib Offerings; Announces Strategic Acquisition and New Partnerships in Monitoring and Therapy

SAN FRANCISCO, May 9, 2019 /PRNewswire/ — Today at the 40th annual Heart Rhythm Scientific Sessions, Acutus Medical announced the agreement to acquire Rhythm Xience, Inc., and new strategic partnerships with Peerbridge Health, Cardiac Designs and MedFact. Acutus’ expanded portfolio builds on the organization’s unprecedented mapping and visualization technology platform. Acutus is committed to helping […]

Vytronus Reaches Enrollment Milestone in Clinical Trial of Automated Ultrasound Technology for Treatment of Persistent Atrial Fibrillation

SUNNYVALE, Calif., May 7, 2019 /PRNewswire/ — Vytronus, Inc., a privately held medical device company developing novel technologies for the treatment of cardiac arrhythmias, announced today that its early feasibility study of automated ultrasound technology for the treatment of persistent atrial fibrillation recently passed the midpoint in patient enrollment and is on track […]

Ablacon, Inc. Raises $21.5M Series A to Advance AI-Enabled Atrial Fibrillation Mapping System

MENLO PARK, Calif., April 30, 2019 /PRNewswire/ — Ablacon, Inc. (www.ablacon.com), a Wheat Ridge, CO-based company developing an advanced mapping system to guide the treatment of atrial fibrillation (AFib), today announced the closing of a $21.5 million Series A financing round led by Ajax Health.  Ablacon’s novel algorithm uses artificial intelligence (AI) to analyze and visualize […]

Alchem ​​International Solves Stability Problems in Micronized Digoxin and Files Patent for New Manufacturing Process

GENEVA, April 25, 2019 / PRNewswire / – Alchem ​​International Private Limited (“Alchem”), a privately held pharmaceutical company specializing in the production of plant-derived active pharmaceutical ingredients (APIs), today announced the launch of its platform owner of micronized digoxin. The Alchem ​​molecule is the only micronized digoxin available worldwide that […]

Espero BioPharma Announces Tecarfarin Receives FDA Orphan Drug Designation for Patients with End Stage Renal Disease and Atrial Fibrillation

JACKSONVILLE, Fla. and IRVINE, Calif., March 11, 2019 (GLOBE NEWSWIRE) — Espero BioPharma, Inc., a pharmaceutical company focused on the development of therapeutics for unmet needs in thrombosis and cardiac rhythm control, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for tecarfarin […]

CardioFocus Initiates Persistent Atrial Fibrillation Study With The Breakthrough HeartLight® X3 System

MARLBOROUGH, Mass., March 5, 2019 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the first enrollments in a clinical study evaluating use of the HeartLight X3 System in an early persistent AFib patient population. The 60 patient, prospective study will be led […]

AtriCure Announces The Society of Thoracic Surgeons Has Endorsed the Company’s Advanced Ablation Courses in the United States

MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatment for atrial fibrillation (Afib) and left atrial appendage management, today announced that The Society of Thoracic Surgeons (STS) has endorsed its Advanced Ablation course for both physicians and fellows. The course provides surgeons and other medical professionals with […]

Kardium Announces New Financing to Commercialize the Globe System for the Treatment of Atrial Fibrillation

VANCOUVER, British Columbia–(BUSINESS WIRE)–Kardium Inc., developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, announced today that it has raised an undisclosed amount in a new financing round. The financing was led by funds and accounts advised by T. Rowe Price Associates, Inc., and included participation from […]

Johnson & Johnson Announces Research Study with Apple Watch to Help Improve AFib Outcomes Including Stroke Prevention

New Brunswick, NJ, January 17, 2019 — Johnson & Johnson (NYSE: JNJ) today announced that Janssen Pharmaceuticals, Inc., member of the Johnson & Johnson Family of Companies, entered into a research study in collaboration with Apple Inc. to investigate whether a new heart health program using an app from Johnson […]